Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Dotton says what our CEO won't. They gave us some good quidance.

I simply think that the company thought that the wise and appropriate response should not be a PTSC/TPL pr when they are in the middle of licensing as it incorporates the decisions of the SC.

Also, the immediate to the the rescue type of response by Dutton, does not jive with their seeemingly independent analysis in previous update

If Dutton got this opinion, separate from PTSC, so much the better!

Share
New Message
Please login to post a reply